基于干细胞的细胞疗法:对外体细胞的生物发生,生物工程和治疗应用的洞察
Mahmood S Choudhery1, Taqdees Arif1, Ruhma Mahmood2
1Department of Human Genetics & Molecular Biology, University of Health Sciences, Lahore 54600, Pakistan.
Biomolecules
|July 27, 2024
概括
使用外体的非细胞干细胞疗法为基于细胞的治疗提供了一个可扩展和可访问的替代方案. 外体提供再生潜力与更少的限制,推进再生医学.
科学领域:
- 再生医学是一种再生医学.
- 细胞生物学 细胞生物学
- 生物技术是生物技术.
背景情况:
- 干细胞疗法有前途,但面临储存和免疫排斥等局限性.
- 无细胞干细胞疗法利用来自干细胞的生物因素,如外体.
- 外体,含有生物活性分子的囊泡,是细胞间通信的关键媒介.
研究的目的:
- 审查对外体的使用作为再生医学的非细胞疗法.
- 探索外体生物发生,隔离和表征方法.
- 讨论生物工程外体的进展及其诊断/治疗应用.
主要方法:
- 对外体生物学和应用的科学文献的综述.
- 对外体隔离和表征技术的分析.
- 检查生物工程策略来增强外体细胞的治疗潜力.
主要成果:
- 外基因组比干细胞具有优势,包括稳定性,易于储存和降低免疫性.
- 基于外体细胞的疗法可以标准化,具有成本效益,并且易于获得.
- 生物工程技术可以提高治疗应用的外体细胞效率.
结论:
- 基于外体的非细胞疗法代表了再生医学中可行的和可扩展的替代方案.
- 外基因组在疾病诊断和治疗中具有多样化的应用.
- 对外体工程和临床翻译的进一步研究是有必要的.
更多相关视频
08:50Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
Published on: August 16, 2024
673
09:20Differentiation of Monocytes into Phenotypically Distinct Macrophages After Treatment with Human Cord Blood Stem Cell CB-SC-Derived Exosomes
Published on: November 12, 2020
5.7K
相关概念视频
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
Clinical Applications of Epidermal Stem Cells
2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K
Stem Cell Culture
5.1K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
5.1K
Mesenchymal Stem Cells
4.7K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.7K
Embryonic Stem Cells
3.4K
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
3.4K
